Corporate Banner
Satellite Banner
Genotyping & Gene Expression
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

TATAA Biocenter Introduces Ingenuity Systems iReport into qPCR Workflow

Published: Wednesday, January 23, 2013
Last Updated: Wednesday, January 23, 2013
Bookmark and Share
TATAA Biocenter, Europe´s leading provider of genomic services using quantitative real-time polymerase PCR (qPCR), is complementing its offerings in high-throughput gene expression profiling with Ingenuity® iReport™.

TATAA Biocenter  is complementing its offerings in high-throughput gene expression profiling with Ingenuity® iReport™. The combined solution enables TATAA Biocenter's laboratories to provide contract research for a full range of real-time qPCR services, including primer and probe design, validation, kit and instrument evaluation, and biological and statistical analysis to academic, pharmaceutical and biotech companies world-wide.


TATAA Biocenter offers a seamless workflow, with all of the instrumentation and sample handing necessary for performing high quality qPCR experiments, and meets the specific requirements for compliance with ISO 17025. Ingenuity iReport enables researchers to quickly and easily identify significant differentially expressed genes and interpret the impact of those expression changes in the context of pathways, phenotypes and molecular interactions.


“The combination of Ingenuity iReport with TATAA Biocenter’s expertise opens up an exciting opportunity for researchers to get access to a complete qPCR workflow,” stated Bryant Macy, SVP Products and Marketing of Ingenuity Systems. “By providing a complete end-to-end workflow including access to iReport, TATAA is enabling researchers to quickly understand the biological meaning of their expression data.”


“The goal of an expression profiling study is to learn the underlying biology. By introducing Ingenuity iReport into our workflow, we are the first service provider to offer experimental design, nucleic acid extraction, QC, profiling, biostatistical and pathways analyses,” says Dr. Mikael Kubista, founder and CEO of TATAA Biocenter. “After thorough evaluation of the various alternatives for pathway analysis available, we decided on iReport, since it provides a smooth workflow with data collected on our OpenArray and BioMark high throughput qPCR platforms, reads batch-wise into GenEx software for multivariate statistical analysis, and provides an easy, accurate, web-based biological and statistical interpretation tool.”

For more information see www.tataa.com or contact us on info@tataa.com


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Douglas Scientific, TATAA Biocenter Collaborate
Both Companies launch new high throughput PCR services.
Tuesday, January 12, 2016
TATAA Partners with Qlucore
TATAA Biocenter introduces partnership with Qlucore to use Qlucore Omics Explorer in its Next Generation Sequencing courses and client services.
Monday, March 09, 2015
Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Cancer Gene-Drug Combinations Ripe for Precision Medicine
The study aims to expand the number of cancer gene mutations that can be paired with a precision therapy.
New Centre Offers Ultra-Speed Protein Analysis
UW-Madison researchers to establish development centre for next-gen protein measurement technologies.
Disrupting Tumour-Promotion in Humans
Researchers have modified an existing protein to represses a specific cancer-promoting ‘message’ within cells.
Drug - Gene 'One-Two' Punch Against Cancer
Researchers identify gene-drug combinations that, together, target and kill cancer cells while not targeting healthy cells.
Drug Candidates Reduce Abnormal Protein Production
New drug candidates improve cell ability to catch miss-folded proteins that could cause deadly diseases.
Liquid Biopsies Treating Ovarian Cancer
Researchers have discovered a promising monitor and treat recurrence of ovarian cancer. Detecting cancer long before tumours reappear.
Diagnostic Thread - Weaving the Future?
Researchers have created diagnostic threads that could pave the way for next-gen implantable and wearable diagnostics.
Unravelling the Roots of Insect’s Waterproof Coating
Researchers have identified the genes that control cuticular lipid production in Drosophila, by performing an RNAi screen and using Direct Analysis in Real Time and GC-MS.
RNA Suppresses Inflammation
Researchers identify a long noncoding RNA that regulates innate immunity.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!